R

RUBYnanomed

9 employees

Ruby Nanomed develops a microfluidic-based liquid biopsy device for cancer progression.

Basic info

Industry

wellness and fitness services

Sectors

medical devices
oncology
microfluidic devices
healthcare
circulating tumour cells
cancer monitoring
liquid biopsy
Health Care
companion diagnostics
in-vitro diagnosis

Date founded

2018

Funding rounds raised

Total raised

$119K

from 1 investors over 1 rounds

R

RUBYnanomed raised $119K on March 5, 2021

Investors: Portugal Ventures

FAQ